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R347P and  R347H:  two mutat ions  occur r ing  in the same t r inudeot ide  
associated with  di f ferent phenorypes 
I. Dugudl~r oux, V. Scotet, M.P. Audrdzet, C. F&ec, M. De  Br  aekeleer 
Facultd de Mddecine & CHU Morvan wM INSERM U-613, Brest, France 
Several mutations are known to occur in the trinucleotide coding for residue 347 of 
the CFTR protein: R347C, R347L, R347H, R347R Using the French Cystic fibrosis 
Registry, we  compared the phenotypic characteristics of 13 patients with the 
R347P/AF508 genotype to those of 7 patients with R347H/AF508. Patients with 
R347P/AF508 were diagnosed earlier than the R347H/AF508 patients (median age: 
23 months vs. 62 months). The mean sweat chloride concentration was higher 
among the R347P/AF508 patients (116.4 vs. 68.5 mEq/l, P=0.005). Pancreatic 
insufficiency was observed in 77% of the R347P/AF508 patients versus 28% among 
the R34714/AF508 patients (P=0.07). Pulmonary function was better, although not 
significantly, in the R34714/AF508 group than among the R347P/AF508 patients 
(FVC: 93.7% vs. 75.2% of predicted values, FEV I :  78.5% vs. 65.6%). 46% of the 
R347P/AF508 patients, but none in the R347H/AF508 group, had Pseudomonas 
aeruginosa. More R347P/AF508 patients than those with R347H/AF508 required 
intravenous antibiotic ures (61.5% vs. 14.3%, P =0.04). Residue 347 of the CFTR 
protein is a positively charged amino acid within the putative transmembrane 
sequence #6 of the firsCt membrane spanning domain (part of the channel pore). This 
arginine residue, a basic amino acid, is conserved across species and l ikely to play 
an important functional role. Its mbstitution by another basic residue, such as 
histidine or lysine, has a l imited effect on channel conductance, leading, as 
observed, to a mild phenotype. On the contrary, substitution by a proline residue, 
known to play a major structural role by kinking c{ helices, decreases conductance 
by more than 70%. This leads to a more severe pbenotype, as observed. 
Supported by "Vaincr e la Mucoviscidose". 
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The influence of a premature termination codon introduced by the 
frameshift mutation 3905insT on nonsense-mediated mRNA decay 
response, splicing and protein Iocalisation 
J. Sanz, B. Steiner, A. Schaller, S. Gallati 
Division of Human Genetics, University of Bertg Switzerland 
The 3905insT mutation accounts for the second most common (4.8%) CFTR gene 
mutation in the Swiss population. The mutation leads to a premature termination 
codon (PTC) 16 bp downstream of the insertion. PTCs can activate the nonsense 
mediated mRNA decay (NMI))  and ha some cases also interfere with the correct 
splicing of the mRNA. The aim of the study was to investigate the effects of the 
3905insT mutation at mRNA and protein level to f ind a molecular explanation for 
the observed severe phenotype. 
Treatment of EB%tr  ansfor med lympbccytes with pur omycin, an inhibitor of NMI) ,  
and performance of semi quantitative RTPCR demonstrated that the mRNA 
carrying the 3905insT mutation is only partially degraded (3050%)  by NMI)  ha six 
patients with a 3905insT/delF508 genotype. Furthermore, one step RT PCR showed 
that the mutat ion does not lead to skipping of exon 20. In addition, 
immtmocytochemical analysis of nasal epithelial cells collected in 5 patients with a 
3905insT/delF508 genotype revealed no CFFR protein at the apical membrane. 
Instead, most of the CFTR protein was lccalized to the Golgi compartment, a 
lccalisation pattern very similar to the one we observed ha cells of delF508 
homozygous patients. 
Our results demonstrate hat the 3905insT mutation triggers only a partial NMI)  
response and does not affect splicing of exon 20. Moreover, we showed that the 
presumably truncated CFI'R protein arising from the tmdegr aded 3905insT mRNA 
is not present at the apical membrane and that the lccalisation pattern resembles the 
one seen in delF508 homozygous patients. Taken together, these res'alts provide a 
good molecular explanation for the severe phenotype observed in patients carrying 
the 3905insT mutation. 
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TranscripSon analysis in individuals with homozygous presence 5T 
allele 
A. Hol~ikov~ 1, I. Val~kov~ 2,R. Gaillyov~ 2 
eRegionaI CF Centre, Masaryk Univer~ity-SchooI of Medicine wul University 
Hospital Brno, Czech Republ&, 2Department of Medical Genetics, Univemity 
Hospital Brno, Czech RepubIik 
Introduction: Cystic fibrosis (CF) as a monogenic disorder presents with a wide 
phenotypic heterogenity. One important question is the mechanism underlying the 
high variabil ity in disease manifestation among individuals with the same genotype. 
Aims: Alternative splicing may be one of contributing factors. It is known that exon 
9 altemative splicing is modulated by the polymorpbic T repeats within the 3 
splicesite region is modulated of intron 8, and that CFTR transcripts missing exon 
9 wi l l  not produced afunctional channel. Methods: We study the molecular basis for 
variability among three children with homozygous presence 5T al lele which can 
lead to exon skipping. 
Results: Two of them manifest some typical CF symptom as cbronic sinusitis, 
repeated respiratory tract diseases, malnutrit ion or pr olapsus recti. The third child is 
without may manifesCtation. Al l  sweat ests were normal. 
Conclusion: Our t anscript analysis ystem may be used as an efficient dia~nosCtic 
tool in CFTR pre mRNA splicing pathology associated to exon 9, the skipping of 
which has been associated to different phenotypes. A child with 5T/5T allele mad 
symptoms has to be taken in dispensary care. 
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R75Q variant of CFTR gene in COPD patients 
A. Nikol ic l, A. Divac l, B. Tomic l, M. Stankovic l, K. Nackaerts 3,H. Cuppens 2, D. 
Radojkovic la  
elMGGE, Belgrade, Serbia & Montenegro, 2Department fo  Human Genetics, 
Catholic University Leuve~ Belgium, ~Department of PuImonology, University 
Hospital Gasthuisberg, Catholic University Leuverg Belgium 
We studied the possible involvement of CFFR R75Q variant in chronic obstmctive 
pulmonary disease (COPD). 
The study included 57 Serbian and 75 Belgian COPD patients and control 
population (103 Serbian and 78 Belgian blood donors). R75Q variant was detected 
by DGGE analysis of CFI'R exon 3, fol lowed by direct DNA sequencing. 
The R75Q was found in 5 Serbian patients, 4 of them being heter ozygous carriers, 
whi le  one was homozygous. In the control group R75Q was present ha two 
individuals. Two Belgian patients were heterozygous carriers of R75Q, and 5 
heter ozygous cancier s were detected in Belgian control population. 
In Serbian patients the allelic frequency of R75Q was significantly higher then in 
control population (5.26%, 0.97%, P=0.019, 95%CI: 1.125 28.554), whi le  Belgian 
patients and controls did not differ significantly (1.33%, 3.21%, P=0.274, 95%CI: 
0.078 2.137). Since R75Q is relatively frequent in general  population and the 
number of individuals analyzed in this study was relatively small, these results can 
not either confirm or exclude the possible role of CFTR R75Q ha the development 
of COPD. Analysis of larger number of patients and controls and studies of other 
populations would be able to offer statistically more significant data, whi le  only 
functional studies could reveal the exact phenotypic onsequence of CFTR R75Q 
variant. In attempt to explain etiology of COPD and possible role of CFTR R75Q, 
other factors should be taken in consideration, both genetic (modifier genes) and 
environmental (smoking). 
